Differential In Vitro and In Vivo Effects of All-Trans Retinoic Acid on the Growth of Human Myeloma Cells
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 30 (3-4) , 361-366
- https://doi.org/10.3109/10428199809057547
Abstract
The effects of all trans retinoic acid (ATRA) on human myeloma cells growth were studied in vitro and in vivo using immunodeficient mice engrafted with malignant plasma cells. ATRA inhibited the in vitro proliferation of plasma cells originating from two patients with multiple myeloma whereas it had no effect on the in vivo growth of plasma cell grafts as assessed by the serial study of human Ig levels in mouse serum. Thus, the efficacy of ATRA for the treatment of human multiple myeloma remains to be ascertained.Keywords
This publication has 8 references indexed in Scilit:
- Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosisClinical and Experimental Immunology, 1996
- Retinoic acid inhibits the growth of human myeloma cells in vitroBritish Journal of Haematology, 1995
- Hypercalcaemia and increased serum interleukin‐6 levels induced by all‐trans retinoic acid in patients with multiple myelomaBritish Journal of Haematology, 1995
- Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction [see comments]Blood, 1994
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Separation of human myeloma cells from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitroBlood, 1988
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Differentiation by Interleukin 2 of a Subpopulation of Human B CellsScandinavian Journal of Immunology, 1986